Please tell us more about yourself below, so we can provide you with the most helpful information, updates on living with diabetes, and ongoing support.
If you prefer to register for Cornerstones4Care® by phone, you can
call 1‑800‑727‑6500 Monday through Friday from 8:30 AM to 6:00 PM to enroll with one of our Cornerstones4Care® professionals.
If you are taking any of the medications listed, please see Important Safety Information below, including links to Prescribing Information and Medication Guides.
Ozempic® (semaglutide) injection 0.5 mg or 1 mg; Victoza® (liraglutide) injection 1.2 mg or 1.8 mg; Xultophy® 100/3.6 (insulin degludec and liraglutide injection) 100 units/mL and 3.6 mg/mL; Tresiba® (insulin degludec injection) 100 U/mL, 200 U/mL; Levemir® (insulin detemir injection) 100 U/mL; Fiasp® (insulin aspart injection) 100 U/mL; NovoLog® (insulin aspart injection) 100 U/mL; NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart injectable suspension) 100 U/mL; Novolin® R (insulin human injection) 100 U/mL; Novolin® N (isophane insulin human suspension) 100 U/mL; Novolin® 70/30 (human insulin isophane suspension and human insulin injection) 100 U/mL
Ozempic® (semaglutide) injection 0.5 mg or 1 mg is an injectable prescription medicine used:
It is not known if Ozempic® can be used in people who have had pancreatitis.
Ozempic® is not a substitute for insulin and is not for use in people with type 1 diabetes or people with diabetic ketoacidosis.
It is not known if Ozempic® is safe and effective for use in children under 18 years of age.
Do not share your Ozempic® pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.
Ozempic® may cause serious side effects, including:
Do not use Ozempic® if:
Before using Ozempic®, tell your health care provider if you have any other medical conditions, including if you:
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements, and other medicines to treat diabetes, including insulin or sulfonylureas.
Ozempic® may cause serious side effects, including:
The most common side effects of Ozempic® may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation.
Please click here for Ozempic® Prescribing Information and Medication Guide.
Victoza® (liraglutide) injection 1.2 mg or 1.8 mg is an injectable prescription medicine used:
Victoza® is not for use in people with type 1 diabetes. It should not be used with other medicines that contain liraglutide. It is not known if Victoza® is safe and effective to lower blood sugar in children under 10 years of age.
Victoza® may cause serious side effects, including:
Do not use Victoza® if:
Before using Victoza®, tell your health care provider if you:
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements, and other medicines to treat diabetes, including insulin or sulfonylureas.
Victoza® may cause serious side effects, including:
The most common side effects of Victoza® may include nausea, diarrhea, vomiting, decreased appetite, indigestion, and constipation.
Please click here for Victoza® Prescribing Information and Medication Guide.
Xultophy® 100/3.6 is an injectable prescription medicine that contains 2 diabetes medicines, insulin degludec, 100 units/mL, and liraglutide, 3.6 mg/mL. Xultophy® 100/3.6 should be used along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes mellitus.
Xultophy® 100/3.6 may cause serious side effects, including:
Do not use Xultophy® 100/3.6 if:
Tell your health care provider about all your medical conditions, including if you:
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Before using Xultophy® 100/3.6, talk to your health care provider about low blood sugar and how to manage it.
Your dose of Xultophy® 100/3.6 may need to change because of change in level of physical activity or exercise, weight gain or loss, increased stress, illness, change in diet, or other medicines you take.
Xultophy® 100/3.6 may cause serious side effects that can be life‑threatening, including:
The most common side effects of Xultophy® 100/3.6 may include stuffy or runny nose, sore throat, headache, nausea, diarrhea, increased blood levels of lipase, and upper respiratory tract infection.
Please see full Prescribing Information and Medication Guide for Xultophy® 100/3.6.
Do not share your Tresiba® FlexTouch® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection, or get a serious infection from them.
Do not take Tresiba® if you:
Before taking Tresiba®, tell your health care provider about all your medical conditions, including if you are:
Talk to your health care provider about low blood sugar and how to manage it.
Tresiba® may cause serious side effects that can be life-threatening, including:
Your insulin dose may need to change because of change in level of physical activity or exercise, increased stress, change in diet, weight gain or loss, or illness.
Common side effects may include reactions at the injection site, itching, rash, serious allergic reactions (whole body reactions), skin thickening or pits at the injection site (lipodystrophy), weight gain, and swelling of your hands and feet.
Get emergency medical help if you have trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, or confusion.
Please click here for Tresiba® Prescribing Information.
Do not share your Levemir® FlexTouch with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.
Do not take Levemir® if:
Before taking Levemir®, tell your health care provider about all your medical conditions including, if you are:
Talk to your health care provider about how to manage low blood sugar.
Serious side effects can lead to death, including:
Low blood sugar. Some signs and symptoms include:
Your insulin dose may need to change because of:
Other common side effects may include:
Get emergency medical help if you have:
Please click here for Levemir® Prescribing Information.
Do not share your Fiasp® with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.
Do not take Fiasp® if:
Before taking Fiasp® tell your health care provider about all your medical conditions including, if you:
Talk to your health care provider about low blood sugar and how to manage it.
Serious side effects can lead to death, including:
Your insulin dose may need to change because of:
Common side effects of Fiasp® may include:
Please click here for Fiasp® Prescribing Information.
Do not share your NovoLog® FlexPen®, NovoLog® FlexTouch®, PenFill® cartridge or PenFill® cartridge compatible insulin delivery device with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.
Do not take NovoLog® if:
Before taking NovoLog®, tell your health care provider about all your medical conditions including, if you are:
Talk to your health care provider about how to manage low blood sugar.
Serious side effects can lead to death, including:
Low blood sugar. Some signs and symptoms include:
Your insulin dose may need to change because of:
Other common side effects may include:
Get emergency medical help if you have:
Please click here for NovoLog® Prescribing Information.
Do not share your NovoLog® Mix 70/30 FlexPen® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection, or get a serious infection from them.
Do not use NovoLog® Mix 70/30 if your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients.
Before taking NovoLog® Mix 70/30, tell your healthcare provider about all your medical conditions including, if you are:
Talk to your health care provider about how to manage low blood sugar.
Serious side effects can lead to death, including:
Low blood sugar. Some signs and symptoms include:
Your insulin dose may need to change because of:
Other common side effects may include:
Get emergency medical help if you have:
Please click here for NovoLog® Mix 70/30 Prescribing Information.
Do not share your Novolin® R FlexPen or syringes with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Do not take Novolin® R if:
Before taking Novolin® R, tell your health care provider about all your medical conditions including, if you are:
Talk to your health care provider about how to manage low blood sugar.
Serious side effects can lead to death, including:
Low blood sugar. Some signs and symptoms include:
Your insulin dose may need to change because of:
Other common side effects may include:
Get emergency medical help if you have:
Please click here for Novolin® R Prescribing Information.
Do not share your Novolin® N FlexPen or syringes with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Do not take Novolin® N if:
Before taking Novolin® N, tell your health care provider about all your medical conditions including, if you are:
Talk to your health care provider about how to manage low blood sugar.
Serious side effects can lead to death, including:
Low blood sugar. Some signs and symptoms include:
Your insulin dose may need to change because of:
Other common side effects may include:
Get emergency medical help if you have:
Please click here for Novolin® N Prescribing Information.
Do not share your Novolin® 70/30 FlexPen or syringes with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Do not take Novolin® 70/30 if:
Before taking Novolin® 70/30, tell your health care provider about all your medical conditions including, if you are:
Talk to your health care provider about how to manage low blood sugar.
Serious side effects can lead to death, including:
Low blood sugar. Some signs and symptoms include:
Your insulin dose may need to change because of:
Other common side effects may include:
Get emergency medical help if you have:
Please click here for Novolin® 70/30 Prescribing Information.
Talk to your health care provider about the importance of diet and exercise in your treatment plan.
If you need assistance with prescription drug costs, PhRMA’s Medicine Assistance Tool may help you learn more about the resources available.
Visit MAT.org to learn more.
Fiasp®, FlexPen®, FlexTouch®, Levemir®, Novolin®, NovoLog®, Ozempic®, Tresiba®, Victoza®, and Xultophy® are registered trademarks of Novo Nordisk A/S.
All other trademarks, registered or unregistered, are the property of their respective owners.